Nexgel (NXGL) Equity Average (2018 - 2025)

Nexgel has reported Equity Average for 8 years, with the latest figure at $5.2 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 2.55% year-over-year to $5.2 million; the trailing twelve-month figure through Dec 2025 stood at $5.2 million (down 2.55% YoY), and the FY2025 full-year result was $5.3 million, down 2.52% from the prior year.
• Equity Average for Q4 2025 stood at $5.2 million, down from $5.3 million in the prior quarter.
• The five-year high for Equity Average was $11.2 million in Q1 2022, with the low at $377000.0 in Q3 2021.
• Historically, Equity Average has averaged $5.7 million across 5 years, with a median of $5.5 million in 2024.
• Annual changes were most pronounced in 2021 — Equity Average surged 2724.49% — and 2023, when it sank 33.04%.
• Nexgel's Equity Average stood at $6.3 million in 2021, then rose by 26.14% to $7.9 million in 2022, then declined by 27.96% to $5.7 million in 2023, then decreased by 5.96% to $5.4 million in 2024, then declined by 2.55% to $5.2 million in 2025.
• The last three Equity Average figures came in at $5.2 million (Q4 2025), $5.3 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.